Secretome Therapeutics is currently preparing an open-label, multiple ascending dose phase 1 study to assess STM-01 in patients with HFpEF. The Food and Drug Administration (FDA) has granted Fast ...
Central Phoenix Surgical Center has received approval from various regulatory bodies to add Progenitor Cell Therapy to its list of interventional pain services. Progenitor Cell Proteins are used by ...
SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback